bioXXmed AG (FRA:T5O) Buyback Yield %: 0.00 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T5O bioXXmed AG FRA:T5O
38 GF Score
Price €0.81
GF Value €10.79
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is bioXXmed AG Buyback Yield %?

bioXXmed AG FRA:T5O +5.19% 38 Buyback Yield % is 0.00 as of Jul. 16, 2026. GuruFocus rates FRA:T5O with a GF Score™ of 38/100 and a GF Value™ of €10.79 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 741 Biotechnology companies, bioXXmed AG ranks worse than 134952.63% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

bioXXmed AG's current buyback yield was 0.00%.

bioXXmed AG Buyback Yield % Historical Data

* Premium members only.

The historical data trend for bioXXmed AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

bioXXmed AG Buyback Yield % Chart

bioXXmed AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -74.30 0.00 0.00 0.00

bioXXmed AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:T5O vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, bioXXmed AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

bioXXmed AG Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's Buyback Yield % falls into.


FRA:T5O
38GF Score
bioXXmed AG FRA:T5O
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

bioXXmed AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

bioXXmed AG's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 0.02992
=0.00%

bioXXmed AG's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 0.02992
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
bioXXmed AG (FRA:T5O) has a Buyback Yield % of 0.00 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on bioXXmed AG and its competitors. According to the industry distribution chart, bioXXmed AG ranks #999999 out of 741 companies in the Biotechnology industry.
Is bioXXmed AG's Buyback Yield % too high?
bioXXmed AG's current Buyback Yield % is 0.00. Based on the distribution chart, bioXXmed AG ranks #999999 out of 741 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, bioXXmed AG has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does bioXXmed AG's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, bioXXmed AG ranks #999999 out of 741 companies for Buyback Yield %. This places bioXXmed AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on bioXXmed AG and its competitors. bioXXmed AG's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is bioXXmed AG stock overvalued right now?
Based on GuruFocus' analysis, bioXXmed AG (FRA:T5O) is currently considered Possible Value Trap. The stock's GF Value™ is €10.79, compared to a current price of €0.81 — trading 92.5% below its estimated fair value. The current Buyback Yield % is 0.00. bioXXmed AG's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For bioXXmed AG (FRA:T5O), the current Buyback Yield % is 0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is bioXXmed AG (FRA:T5O) Overvalued in 2026?

Based on GuruFocus' analysis, bioXXmed AG stock appears to be undervalued. The current stock price of €0.81 is trading 92.5% below its estimated GF Value™ of €10.79. GuruFocus considers bioXXmed AG to be Possible Value Trap.

Key valuation signals for FRA:T5O:

  • Buyback Yield %: 0.00
  • GF Value™: €10.79 vs. price of €0.81 (92.5% below fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the FRA:T5O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioXXmed AG Business Description

Other Exchanges T5O:Germany
Address Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
38GF Score

Get the complete analysis for FRA:T5O

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.81
Price
€10.79
GF Value